Retrospective cohort study of estrogen receptor low positive early breast cancer using real world data.

525Background: Estrogen receptor (ER) positive breast cancer (BC) is a heterogeneous disease, with ongoing debate on the optimal cut off point for clinically relevant ER expression. Tumors harborin...